Showing 15,741 - 15,760 results of 16,357 for search '"innovations"', query time: 0.13s Refine Results
  1. 15741
  2. 15742
  3. 15743
  4. 15744
  5. 15745
  6. 15746
  7. 15747
  8. 15748
  9. 15749
  10. 15750
  11. 15751

    The Effective Compound Combination of Bufei Yishen Formula III Improves the Mitochondrial Dysfunction via Inhibiting JNK/Sab Pathway in COPD Mice by Song M, Han M, Zhang H, Yang Y, Tian Y, Li J, Zhao J

    Published 2025-01-01
    “…Mengwei Song,1,2,* Mi Han,1,2,* Haoyu Zhang,1 Yifan Yang,1,2 Yange Tian,1,2 Jiansheng Li,2,3 Jie Zhao1,2 1Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, People’s Republic of China; 2Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province and Education Ministry of P.R. …”
    Get full text
    Article
  12. 15752
  13. 15753

    Nurses’ Perspectives and Experiences of Using a Bed-Exit Information System in an Acute Hospital Setting: Mixed Methods Study by Stefan Walzer, Isabel Schön, Johanna Pfeil, Sam Klemm, Sven Ziegler, Claudia Schmoor, Christophe Kunze

    Published 2025-02-01
    “…Overall, successful integration of BES in acute care settings will require close collaboration with nursing staff to drive meaningful healthcare innovation and ensure that the technology meets the needs of both patients and nurses. …”
    Get full text
    Article
  14. 15754
  15. 15755
  16. 15756
  17. 15757

    Cost drivers associated with autologous stem-cell transplant (ASCT) in patients with relapsed/refractory diffuse large B-cell lymphoma in a Japanese real-world setting: A structura... by Saaya Tsutsué, Shinichi Makita, Hiroya Asou, Shingo Wada, Wen Shi Lee, Dilinuer Ainiwaer, Koki Idehara, Sona-Sanae Aoyagi, Seok-Won Kim, Todd Taylor

    Published 2025-01-01
    “…Structural equation modeling was used to identify potential total healthcare cost drivers by evaluating direct, indirect, and total effects and provide a benchmark reference for future innovative therapies. A total of 108 patients (3.8%) among all DLBCL patients who received SCT met the eligibility criteria and were considered ASCT patients; majority of which were males (n = 63, 58.33%), with a mean [median] (SD) age of 52.04 [55] (9.88) years. …”
    Get full text
    Article
  18. 15758
  19. 15759
  20. 15760